These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35973150)

  • 21. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
    Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
    Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
    Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
    J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time to fecal immunochemical test completion for colorectal cancer screening.
    Haas CB; Phipps AI; Hajat A; Chubak J; Wernli KJ
    Am J Manag Care; 2019 Apr; 25(4):174-180. PubMed ID: 30986014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing Fecal Immunochemical Test Return Rates by Implementing Effective "Reminder to Complete Kit" Communication With Participants: A Quality Improvement Study.
    Prakash S; Merza N; Hosseini O; Ward H; Mansi T; Balducci M; Trammell D; Hernandez B; Obokhare I
    Cureus; 2022 May; 14(5):e25169. PubMed ID: 35746986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mobile messenger-initiated reminders improve longitudinal adherence in a community-based, opportunistic colorectal cancer screening program: A single-blind, crossover randomized controlled study.
    Lam TYT; Wu PI; Tang RSY; Luk AKC; Ng S; Sung JJY
    Cancer; 2021 Mar; 127(6):914-921. PubMed ID: 33216357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated telephone calls improved completion of fecal occult blood testing.
    Mosen DM; Feldstein AC; Perrin N; Rosales AG; Smith DH; Liles EG; Schneider JL; Lafata JE; Myers RE; Kositch M; Hickey T; Glasgow RE
    Med Care; 2010 Jul; 48(7):604-10. PubMed ID: 20508529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal Cancer Screening with Mailed Fecal Immunochemical Tests and Telephone Outreach at a Community Health Center during the COVID-19 Pandemic.
    Ritzenthaler D; Deshpande S; Ryan M; Daprano J
    J Health Care Poor Underserved; 2022; 33(2):973-983. PubMed ID: 35574888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
    Selby K; Jensen CD; Levin TR; Lee JK; Schottinger JE; Zhao WK; Corley DA; Doubeni CA
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):145-152. PubMed ID: 33010408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing colorectal cancer screening in an overdue population: participation and cost impacts of adding telephone calls to a FIT mailing program.
    Schlichting JA; Mengeling MA; Makki NM; Malhotra A; Halfdanarson TR; Klutts JS; Levy BT; Kaboli PJ; Charlton ME
    J Community Health; 2014 Apr; 39(2):239-47. PubMed ID: 24499966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
    Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
    BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of a secure email reminder system for colorectal cancer screening.
    Muller D; Logan J; Dorr D; Mosen D
    AMIA Annu Symp Proc; 2009 Nov; 2009():457-61. PubMed ID: 20351899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for Colorectal Cancer at the Worksite.
    O'Keefe LC; Sullivan MM; McPhail A; Van Buren K; Dewberry N
    Workplace Health Saf; 2018 Apr; 66(4):183-190. PubMed ID: 29020876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests.
    Ko CW; Dominitz JA; Nguyen TD
    Am J Med; 2003 Aug; 115(2):111-4. PubMed ID: 12893396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Multi-Level Fit-Based Quality Improvement Initiative to Improve Colorectal Cancer Screening in a Managed Care Population.
    Yu C; Skootsky S; Grossman M; Garner OB; Betlachin A; Esrailian E; Hommes DW; May FP
    Clin Transl Gastroenterol; 2018 Sep; 9(8):177. PubMed ID: 30177700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.
    Rat C; Pogu C; Le Donné D; Latour C; Bianco G; Nanin F; Cowppli-Bony A; Gaultier A; Nguyen JM
    JAMA; 2017 Sep; 318(9):816-824. PubMed ID: 28873160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing Rejected Fecal Immunochemical Tests Received in the Laboratory for Colorectal Cancer Screening.
    Cheng C; Ganz DA; Chang ET; Huynh A; De Peralta S
    J Healthc Qual; 2019; 41(2):75-82. PubMed ID: 30839491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.
    Green BB; Wang CY; Anderson ML; Chubak J; Meenan RT; Vernon SW; Fuller S
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):301-11. PubMed ID: 23460053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change to FIT increased CRC screening rates: evaluation of a US screening outreach program.
    Liles EG; Perrin N; Rosales AG; Feldstein AC; Smith DH; Mosen DM; Schneider JL
    Am J Manag Care; 2012 Oct; 18(10):588-95. PubMed ID: 23145804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.